Antihypertensive efficacy and tolerance of penbutolol: results of a co-operative study in 227 patients

Current Medical Research and Opinion
C MaroneM Borer


An open, co-operative study was carried out in 227 patients with mild to severe essential hypertension to assess the efficacy and tolerance of penbutolol, given as monotherapy, in controlling blood pressure. Patients received a single daily dose (40 mg in the majority) for 8 weeks and were assessed every 2 weeks. The results showed that there was a significant reduction (p less than 0.01) in systolic, diastolic and mean arterial blood pressure and in pulse rate after 2 weeks compared with pre-treatment values, and there was a further significant reduction (p less than 0.01) comparing 8-week values with those measured after 2 weeks. Response to treatment did not differ significantly between those patients who were newly diagnosed and those who had received previous antihypertensive medication. The largest percentage reduction in blood pressure from initial values was recorded in those patients with the more severe hypertension (diastolic 116 to 130 mmHg) and a considerable number of all the patients became normotensive during the trial period. Records of side-effects indicated a global incidence of 17.6%, the most frequently reported being dizziness and mild gastro-intestinal disorders; only 1 patient complained of bradycardia a...Continue Reading


Jan 1, 1979·European Journal of Clinical Pharmacology·G NybergA Vedin
Apr 15, 1978·Lancet·M W Millar-CraigE B Raftery
Jan 1, 1977·The Journal of International Medical Research·V H YajnikS H Patel
Jul 1, 1979·Journal of Clinical Pharmacology·J L CangianoM Martinez-Maldonado
Dec 19, 1981·Lancet·B A GouldE B Raftery
Jan 1, 1984·Hypertension·B J des CombesH R Brunner
Jan 1, 1982·European Journal of Clinical Pharmacology·K P OhmanB Liander
Jan 1, 1982·The Journal of International Medical Research·J J Houtzagers, D R Chadha


Jun 1, 1989·The American Journal of Cardiology·J A Schoenberger

Related Concepts

Antihypertensive Agents
Clinical Trials
Hypertensive Disease

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.


Bradyarrhythmias are slow heart rates. Symptoms may include syncope, dizziness, fatigure, shortness of breath, and chest pains. Find the latest research on bradyarrhythmias here.

Acute viral rhinopharyngitis

Acute viral rhinopharyngitis, also known as "common cold", is an acute, self-limiting viral infection of the upper respiratory tract involving the nose, sinuses, pharynx and larynx. Discover the latest research on acute viral rhinopharyngitis here.